Terms: = Kidney tumors AND PR, PGR, progesterone receptor
577 results:
1. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
2. Cobimetinib Plus Vemurafenib in Patients With Solid tumors With
Meric-Bernstam F; Rothe M; Mangat PK; Garrett-Mayer E; Gutierrez R; Ahn ER; Cannon TL; Powell S; Krauss JC; Reynolds CM; von Mehren M; Behl D; Calfa CJ; Duvivier HL; Kaplan HG; Livingston MB; Sharma MR; Urba WJ; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
JCO Precis Oncol; 2023 Sep; 7():e2300385. PubMed ID: 38096472
[TBL] [Abstract] [Full Text] [Related]
3. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
Zamarud A; Marianayagam NJ; Park DJ; Yener U; Yoo KH; Meola A; Chang SD
J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759
[TBL] [Abstract] [Full Text] [Related]
4. Protocol for a mixed-method study to assess chronic cough in patients with renal cell carcinoma: the prevalence, impact on quality of life, trigger and potential clinical application of chronic cough as an early screening tool in patients with kidney cancer.
Smith W; Loizidou M; Mazzone S; Mumtaz F; Gurusamy K; Ranieri V; Tran MG
BMJ Open; 2023 Nov; 13(11):e074077. PubMed ID: 37949629
[TBL] [Abstract] [Full Text] [Related]
5. Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer.
He S; Wang L; Sun Y; Du H; Yu X
Front Immunol; 2023; 14():1270828. PubMed ID: 37915573
[TBL] [Abstract] [Full Text] [Related]
6. Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study.
Chen M; Li C; Zhang J; Cui X; Tian W; Liao P; Wang Q; Sun J; Luo L; Wu H; Li YG
JMIR Public Health Surveill; 2023 Oct; 9():e40149. PubMed ID: 37847541
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.
Harada KI; Sato R; Bando Y; Sano A; Matsushita Y; Tamura K; Terakawa T; Furukawa J; Fujimoto N; Fujisawa M; Miyake H
Int J Urol; 2023 Sep; 30(9):772-777. PubMed ID: 37345413
[TBL] [Abstract] [Full Text] [Related]
8. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
[TBL] [Abstract] [Full Text] [Related]
9. Three-dimensional Virtual Models of the kidney with Colored Perfusion Regions: A New Algorithm-based Tool for Optimizing the Clamping Strategy During Robot-assisted Partial Nephrectomy.
Amparore D; Piramide F; Checcucci E; Verri P; De Cillis S; Piana A; Volpi G; Busacca G; Colombo M; Fiori C; Porpiglia F
Eur Urol; 2023 Oct; 84(4):418-425. PubMed ID: 37117108
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.
Sharma H; Moturi KR; Pankratz VS; Yilmaz E; Gbolahan OB; Kumar A; Hashemi-Sadraei N
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8673-8680. PubMed ID: 37115270
[TBL] [Abstract] [Full Text] [Related]
11. Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
Chehrazi-Raffle A; Muddasani R; Dizman N; Hsu J; Meza L; Zengin ZB; Malhotra J; Chawla N; Dorff T; Contente-Cuomo T; Dinwiddie D; McDonald BR; McDaniel T; Trent JM; Baehner FL; Murtaza M; Pal SK
JCO Precis Oncol; 2023 Apr; 7():e2200543. PubMed ID: 37027813
[TBL] [Abstract] [Full Text] [Related]
12. Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis.
Haaker L; Baldewijns M; De Wever L; Albersen M; Debruyne PR; Wynendaele W; De Meerleer G; Beuselinck B
Clin Genitourin Cancer; 2023 Aug; 21(4):442-451. PubMed ID: 36997468
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study.
Lu H; Ye Q; Zheng C; Fan L; Xia X
BMC Cancer; 2023 Mar; 23(1):270. PubMed ID: 36964538
[TBL] [Abstract] [Full Text] [Related]
14. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
Li H; Sahu KK; Brundage J; Benson M; Swami U; Boucher KM; Gupta S; Hawks J; Sirohi D; Agarwal N; Maughan BL
Oncologist; 2023 Aug; 28(8):737-e693. PubMed ID: 36952231
[TBL] [Abstract] [Full Text] [Related]
15. Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
Atkins MB; Jegede OA; Haas NB; McDermott DF; Bilen MA; Stein M; Sosman JA; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Signoretti S; Denize T; Cimadamore A; Wu CJ; Braun D; Einstein D; Catalano PJ; Hammers H
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36948504
[TBL] [Abstract] [Full Text] [Related]
16. Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Yang YH; Ansel S; Meerveld-Eggink A; Jackson-Spence F; Rallis K; Brian P; Choy J; Sng C; Adeniran P; Amin J; Galope S; Anderson N; Bex A; Powles T; Venugopal B; Szabados B
Clin Genitourin Cancer; 2023 Aug; 21(4):e242-e251. PubMed ID: 36922286
[TBL] [Abstract] [Full Text] [Related]
17. [Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma].
Wakamiya T; Kubo T; Yamashita S; Kohjimoto Y; Torigoe T; Hara I
Hinyokika Kiyo; 2022 Oct; 68(10):311-315. PubMed ID: 36329378
[TBL] [Abstract] [Full Text] [Related]
18. A/(H1N1) pdm09 NS1 promotes viral replication by enhancing autophagy through hijacking the IAV negative regulatory factor LRPPRC.
Guo X; Zhang Z; Lin C; Ren H; Li Y; Zhang Y; Qu Y; Li H; Ma S; Xia H; Sun R; Zu H; Lin Y; Wang X
Autophagy; 2023 May; 19(5):1533-1550. PubMed ID: 36300799
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma.
Ji X; Jing X; Liu Y; Huang J; Yang S; Yun Y
Dis Markers; 2022; 2022():2483816. PubMed ID: 36277984
[TBL] [Abstract] [Full Text] [Related]
20. ♣Evaluation of clinicopathological profiles and development of a risk model in renal epithelioid angiomyolipoma patients: a large-scale retrospective cohort study.
Anwaier A; Xu WH; Tian X; Ding T; Su JQ; Wang Y; Qu YY; Zhang HL; Ye DW
BMC Urol; 2022 Sep; 22(1):148. PubMed ID: 36096809
[TBL] [Abstract] [Full Text] [Related]
[Next]
